A new oral antiviral drug candidate administered either before or after direct contact or airborne exposure to canine distemper virus, which causes measles-like disease in ferrets, blocks transmission of the virus and reduces clinical symptoms, according to a study published in the journal Nature Microbiology¹ by researchers in the Center for Translational Antiviral Research (CTAR) at Georgia State University.